Name of Faculty Sponsor
Faculty Sponsor Email
This IRB-approved descriptive study provides an overview of the concerns associated with receiving a COVID-19 vaccination within the Kennesaw State University community, an R2 university with over 41,000 students, and uses a survey to provide insight into how students, faculty, staff, and administrators are responding to the vaccinations for COVID-19, both available and unavailable, and their preferences. Our research findings indicate that: 1) Most of the population at Kennesaw State University intends to receive the vaccine, regardless of their concerns; 2) The majority of the participants who are either employed or provided an education by Kennesaw State University plan to get their vaccination for COVID-19 at one of the campus locations; 3) If given a choice, 32.17% preferred the Moderna vaccine, while 26.96% opted for Pfizer, and 37.39% of respondents preferred not to answer; and 4) The KSU community’s primary concerns with receiving either vaccine are the associated direct side effects as well as their unknown long-term effects.
Bellamy, Kaela and Keyser, Robert S.
"Concerns with Taking the COVID-19 Vaccine,"
The Kennesaw Journal of Undergraduate Research: Vol. 9:
1, Article 2.
Available at: https://digitalcommons.kennesaw.edu/kjur/vol9/iss1/2